UK health minister confirms talks with AstraZeneca over new variant vaccines

PUBLISHED: Wed, 02 Jun 2021 14:15:02 GMT

LONDON, June 2 (Reuters) – Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been changed to better target the “beta” coronavirus variant first identified in South Africa, health minister Matt Hancock said on Wednesday.

“We’ve started commercial negotiations with AstraZeneca to secure a variant vaccine: future supplies of the Oxford AstraZeneca vaccine that have been adapted to tackle the B.1.351 variant first identified in South Africa,” Hancock said in a speech at Oxford University. (Reporting by Alistair Smout; editing by Costas Pitas)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.